Vascular Endothelial Growth Factor Inhibitors [MoA] - N0000193542

  1. Home
  2. Pharmacologic Class Index
  3. Vascular Endothelial Growth Factor Inhibitors [MoA] - N0000193542

Pharmacologic Class Information

Pharmacologic Code N0000193542
Pharmacologic Name Vascular Endothelial Growth Factor Inhibitors
Pharmacologic Uses
  • vascular endothelial growth factor (VEGF) inhibitor
  • vascular endothelial growth factor-specific angiogenesis inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Vascular Endothelial Growth Factor Inhibitors

The following table contains 19 products whose active ingredient are classified under the same pharmacologic class Vascular Endothelial Growth Factor Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-5840Zaltrap Non-Proprietary Name: Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0024-5841Zaltrap Non-Proprietary Name: Ziv-afliberceptSolution, ConcentrateIntravenousSanofi-aventis U.s. LlcACTIVE
0069-0315Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0342Zirabev Non-Proprietary Name: Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-060Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Avastin Non-Proprietary Name: BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-078Susvimo Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-080Lucentis Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
50242-082Lucentis Non-Proprietary Name: RanibizumabInjection, SolutionIntravitrealGenentech, Inc.ACTIVE
55513-206Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Mvasi Non-Proprietary Name: Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
61755-005Eylea Non-Proprietary Name: AfliberceptInjection, SolutionIntravitrealRegeneron Pharmaceuticals, Inc.ACTIVE
64406-019Byooviz Non-Proprietary Name: Ranibizumab-nunaInjection, SolutionIntravitrealBiogen Inc.ACTIVE
70114-440Cimerli Non-Proprietary Name: Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70114-441Cimerli Non-Proprietary Name: Ranibizumab-eqrnInjection, SolutionIntravitrealCoherus Biosciences IncACTIVE
70121-1754Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Alymsys Non-Proprietary Name: Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
72606-011Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCellrion Usa, Inc.ACTIVE
72606-012Vegzelma Non-Proprietary Name: Bevacizumab-adcdInjection, SolutionIntravenousCellrion Usa, Inc.ACTIVE